Phase I Clinical Trial of Human Anti-PD-L1 Antibody Injection (LDP) in Patients With Advanced Malignant Tumors

NCT03908814 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Tumors

Interventions

DRUG: Whole Human Anti-PD-L1 Antibody Injection (LDP)

Sponsor

Dragonboat Biopharmaceutical Company Limited

Collaborators

[object Object]